-
Something wrong with this record ?
ORMDL2 Deficiency Potentiates the ORMDL3-Dependent Changes in Mast Cell Signaling
V. Bugajev, I. Halova, L. Demkova, S. Cernohouzova, P. Vavrova, M. Mrkacek, P. Utekal, L. Draberova, L. Kuchar, B. Schuster, P. Draber
Language English Country Switzerland
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2010
Free Medical Journals
from 2010
PubMed Central
from 2010
Europe PubMed Central
from 2010
Open Access Digital Library
from 2010-01-01
Open Access Digital Library
from 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2010
- MeSH
- Anaphylaxis etiology metabolism MeSH
- Biomarkers MeSH
- Chemotaxis immunology MeSH
- Cytokines metabolism MeSH
- Gene Expression MeSH
- Lysophospholipids blood metabolism MeSH
- Mast Cells immunology metabolism MeSH
- Membrane Proteins chemistry deficiency genetics metabolism MeSH
- Multigene Family MeSH
- Mice, Knockout MeSH
- Mice MeSH
- Disease Susceptibility MeSH
- Passive Cutaneous Anaphylaxis genetics immunology MeSH
- Amino Acid Sequence MeSH
- Sphingolipids blood metabolism MeSH
- Sphingosine analogs & derivatives blood metabolism MeSH
- Signal Transduction * MeSH
- Calcium metabolism MeSH
- Calcium Signaling MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The systemic anaphylactic reaction is a life-threatening allergic response initiated by activated mast cells. Sphingolipids are an essential player in the development and attenuation of this response. De novo synthesis of sphingolipids in mammalian cells is inhibited by the family of three ORMDL proteins (ORMDL1, 2, and 3). However, the cell and tissue-specific functions of ORMDL proteins in mast cell signaling are poorly understood. This study aimed to determine cross-talk of ORMDL2 and ORMDL3 proteins in IgE-mediated responses. To this end, we prepared mice with whole-body knockout (KO) of Ormdl2 and/or Ormdl3 genes and studied their role in mast cell-dependent activation events in vitro and in vivo. We found that the absence of ORMDL3 in bone marrow-derived mast cells (BMMCs) increased the levels of cellular sphingolipids. Such an increase was further raised by simultaneous ORMDL2 deficiency, which alone had no effect on sphingolipid levels. Cells with double ORMDL2 and ORMDL3 KO exhibited increased intracellular levels of sphingosine-1-phosphate (S1P). Furthermore, we found that concurrent ORMDL2 and ORMDL3 deficiency increased IκB-α phosphorylation, degranulation, and production of IL-4, IL-6, and TNF-α cytokines in antigen-activated mast cells. Interestingly, the chemotaxis towards antigen was increased in all mutant cell types analyzed. Experiments in vivo showed that passive cutaneous anaphylaxis (PCA), which is initiated by mast cell activation, was increased only in ORMDL2,3 double KO mice, supporting our in vitro observations with mast cells. On the other hand, ORMDL3 KO and ORMDL2,3 double KO mice showed faster recovery from passive systemic anaphylaxis, which could be mediated by increased levels of blood S1P presented in such mice. Our findings demonstrate that Ormdl2 deficiency potentiates the ORMDL3-dependent changes in mast cell signaling.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019259
- 003
- CZ-PrNML
- 005
- 20210830100834.0
- 007
- ta
- 008
- 210728s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fimmu.2020.591975 $2 doi
- 035 __
- $a (PubMed)33643282
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Bugajev, Viktor $u Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
- 245 10
- $a ORMDL2 Deficiency Potentiates the ORMDL3-Dependent Changes in Mast Cell Signaling / $c V. Bugajev, I. Halova, L. Demkova, S. Cernohouzova, P. Vavrova, M. Mrkacek, P. Utekal, L. Draberova, L. Kuchar, B. Schuster, P. Draber
- 520 9_
- $a The systemic anaphylactic reaction is a life-threatening allergic response initiated by activated mast cells. Sphingolipids are an essential player in the development and attenuation of this response. De novo synthesis of sphingolipids in mammalian cells is inhibited by the family of three ORMDL proteins (ORMDL1, 2, and 3). However, the cell and tissue-specific functions of ORMDL proteins in mast cell signaling are poorly understood. This study aimed to determine cross-talk of ORMDL2 and ORMDL3 proteins in IgE-mediated responses. To this end, we prepared mice with whole-body knockout (KO) of Ormdl2 and/or Ormdl3 genes and studied their role in mast cell-dependent activation events in vitro and in vivo. We found that the absence of ORMDL3 in bone marrow-derived mast cells (BMMCs) increased the levels of cellular sphingolipids. Such an increase was further raised by simultaneous ORMDL2 deficiency, which alone had no effect on sphingolipid levels. Cells with double ORMDL2 and ORMDL3 KO exhibited increased intracellular levels of sphingosine-1-phosphate (S1P). Furthermore, we found that concurrent ORMDL2 and ORMDL3 deficiency increased IκB-α phosphorylation, degranulation, and production of IL-4, IL-6, and TNF-α cytokines in antigen-activated mast cells. Interestingly, the chemotaxis towards antigen was increased in all mutant cell types analyzed. Experiments in vivo showed that passive cutaneous anaphylaxis (PCA), which is initiated by mast cell activation, was increased only in ORMDL2,3 double KO mice, supporting our in vitro observations with mast cells. On the other hand, ORMDL3 KO and ORMDL2,3 double KO mice showed faster recovery from passive systemic anaphylaxis, which could be mediated by increased levels of blood S1P presented in such mice. Our findings demonstrate that Ormdl2 deficiency potentiates the ORMDL3-dependent changes in mast cell signaling.
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a anafylaxe $x etiologie $x metabolismus $7 D000707
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologické markery $7 D015415
- 650 _2
- $a vápník $x metabolismus $7 D002118
- 650 _2
- $a vápníková signalizace $7 D020013
- 650 _2
- $a chemotaxe $x imunologie $7 D002633
- 650 _2
- $a cytokiny $x metabolismus $7 D016207
- 650 _2
- $a náchylnost k nemoci $7 D004198
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a lysofosfolipidy $x krev $x metabolismus $7 D008246
- 650 _2
- $a mastocyty $x imunologie $x metabolismus $7 D008407
- 650 _2
- $a membránové proteiny $x chemie $x nedostatek $x genetika $x metabolismus $7 D008565
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a multigenová rodina $7 D005810
- 650 _2
- $a pasivní kožní anafylaxe $x genetika $x imunologie $7 D010323
- 650 12
- $a signální transdukce $7 D015398
- 650 _2
- $a sfingolipidy $x krev $x metabolismus $7 D013107
- 650 _2
- $a sfingosin $x analogy a deriváty $x krev $x metabolismus $7 D013110
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Halova, Ivana $u Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Demkova, Livia $u Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Cernohouzova, Sara $u Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Vavrova, Petra $u Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Mrkacek, Michal $u Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Utekal, Pavol $u Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Draberova, Lubica $u Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Kuchar, Ladislav $u Research Unit for Rare Diseases, Department of Pediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
- 700 1_
- $a Schuster, Björn $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
- 700 1_
- $a Draber, Petr $u Department of Signal Transduction, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia
- 773 0_
- $w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 11, č. - (2020), s. 591975
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33643282 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830100835 $b ABA008
- 999 __
- $a ok $b bmc $g 1690152 $s 1139705
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 11 $c - $d 591975 $e 20210211 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
- LZP __
- $a Pubmed-20210728